MedPath

Comparing the effect of insulin and metformin with that of insulin in pregnant women with Diabetes

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: O244- Gestational diabetes mellitus
Registration Number
CTRI/2022/02/039941
Lead Sponsor
Jawaharlal Institute of Postgraduate Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PREGNANT WOMEN DIAGNOSED WITH DIABETES IN PREGNANCY (WHO CRITERIA)

1) > 18 YRS AGE

2) SINELTON FOETUS

3) WOMEN ON RECEIVING INSULIN AND METFORMIN

(EITHER THERAPY STARTRED INITIALLY)/WOMEN ON

INSULIN THERAPY ALONE

4) RECEIVING REGULAR+/- NPH INSULI

Exclusion Criteria

PREGNANT WOMEN ON INSULIN PUMP

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO DETERMINE AND COMPARE THE PREGNANCY OUTCOME IN WOMEN WITH DIABETES IN PREGNANCY RECEIVING COMBINATION OF INSULIN AND METFORMIN WITH THAT OF INSULIN ALONETimepoint: 9 months
Secondary Outcome Measures
NameTimeMethod
TO CORRELATE THE DRUG CHARACTERSTICS WITH THE PREGNANCY OUTCOMETimepoint: 9 months
© Copyright 2025. All Rights Reserved by MedPath